Ergomed Plc

('Ergomed' or the 'Company')

PDMR Dealing

Ergomed, a company focused on providing specialised services to the pharmaceutical industry, announces that on 7 June 2019, Richard Barfield, Chief Financial Officer of the Company, purchased 36,000 ordinary shares of 1 pence each in the Company ('Share(s)') at a price of 241.5 pence per Share (the 'Purchase').

Following the Purchase, Richard Barfield's holding in the Company is 36,000 Shares (representing 0.08 per cent. of the Company's issued share capital).

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Richard Barfield

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ergomed Plc

b)

Legal Entity Identifier

213800BVS8I9VMC1AP84

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

GB00BN7ZCY67

b)

Nature of the transaction

Purchase of Shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

241.5 pence

36,000

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

Volume: 36,000 ordinary shares of 1 pence each, purchase price of 241.5 pence per share

Aggregated: £86,940.00

f)

Date of the transaction

07 June 2019

g)

Place of the transaction

London Stock Exchange, AIM

Enquiries:

Ergomed plc

Tel: +44 (0) 1483 402 975

Miroslav Reljanović (Executive Chairman)

Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Freddie Barnfield (Nominated Adviser)

James Black (Broker)

Consilium Strategic Communications - for UK enquiries

Tel: +44 (0) 20 3709 5700

Chris Gardner / Mary-Jane Elliott

ergomed@consilium-comms.com

Matthew Neal / Olivia Manser

MC Services - for Continental European enquiries

Tel: +49 211 52925222

Anne Hennecke

Attachments

  • Original document
  • Permalink

Disclaimer

Ergomed plc published this content on 10 June 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 10 June 2019 09:27:07 UTC